Dr. Brian King

Brian King, PhD, MPH, was the director of the Center for Tobacco Products at the U.S. Food and Drug Administration (FDA). Prior to joining FDA, he served as the deputy director for research translation in the Office on Smoking and Health (OSH) at the Centers for Disease Control and Prevention (CDC). Dr. King joined the CDC in 2010 as an epidemic intelligence service officer, before which he worked as a research affiliate in the Division of Cancer Prevention and Population Sciences at Roswell Park Comprehensive Cancer Center in Buffalo, New York.

Dr. King has worked for over 20 years to provide sound scientific evidence to inform tobacco control policy and to effectively communicate this information to key stakeholders, including decision-makers, the media, and the general public. He has authored or co-authored over 225 peer-reviewed scientific articles pertaining to tobacco prevention and control, was the lead author of CDC’s 2014 update to the evidence-based state guide, “Best Practices for Comprehensive Tobacco Control Programs,” and was the senior associate editor of numerous U.S. Surgeon General’s Reports on tobacco. Dr. King holds a PhD and MPH in epidemiology from the State University of New York at Buffalo.